{"id":128895,"date":"2023-04-15T05:40:27","date_gmt":"2023-04-15T05:40:27","guid":{"rendered":"http:\/\/pressarabia.qa\/?guid=f3323b36f49d7054647d94481f322b01"},"modified":"2023-04-15T05:40:27","modified_gmt":"2023-04-15T05:40:27","slug":"srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt","status":"publish","type":"post","link":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/","title":{"rendered":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT"},"content":{"rendered":"
\n

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) —<\/p>\n

WHY: <\/strong>Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public.<\/p>\n

SO WHAT:<\/strong> If you purchased Sarepta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.<\/p>\n

WHAT TO DO NEXT: <\/strong>To join the prospective class action, go to https:\/\/rosenlegal.com\/submit-form\/?case_id=1306<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a> for information on the class action.<\/p>\n

WHAT IS THIS ABOUT:<\/strong> On March 16, 2023, after market hours, the Company issued a press release which \u201cannounced that at its late cycle meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA), the U.S. Food and Drug Administration\u2019s Office of Therapeutics (OTP) has determined that an advisory committee meeting will be held for SRP-9001 in advance of the May 29, 2023 regulatory action date.\u201d<\/p>\n

As explained by the Investor\u2019s Business Daily<\/em> in an article entitled \u201cSarepta Crashes on an Unexpected Roadblock for Its Gene Therapy\u201d, the Food and Drug Administration\u2019s decision was a surprise. The article quoted a UBS analyst as saying that \u201cgiven the announcement of the advisory committee decision, against a backdrop of the Office of Therapeutics communicating how capacity constrained it is at every public appearance, we do see a potential risk of (approval date) extension.\u201d<\/p>\n

On this news, the price of Sarepta\u2019s stock fell $26.98, or 18%, to close at $122.69 per share on March 17, 2023, the next trading day.<\/p>\n

WHY ROSEN LAW: <\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

——————————–<\/p>\n

Contact Information:<\/p>\n

Laurence Rosen, Esq.
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\nlrosen@rosenlegal.com<\/a>
\npkim@rosenlegal.com<\/a>
\ncases@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a> <\/p>\n

GlobeNewswire Distribution ID 8808201<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nSRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\" \/>\n<meta property=\"og:site_name\" content=\"Press Arabia\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-15T05:40:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2\"},\"headline\":\"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT\",\"datePublished\":\"2023-04-15T05:40:27+00:00\",\"dateModified\":\"2023-04-15T05:40:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\"},\"wordCount\":559,\"publisher\":{\"@id\":\"https:\/\/pressarabia.qa\/#organization\"},\"image\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\",\"url\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\",\"name\":\"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia\",\"isPartOf\":{\"@id\":\"https:\/\/pressarabia.qa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=\",\"datePublished\":\"2023-04-15T05:40:27+00:00\",\"dateModified\":\"2023-04-15T05:40:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage\",\"url\":\"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=\",\"contentUrl\":\"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pressarabia.qa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pressarabia.qa\/#website\",\"url\":\"https:\/\/pressarabia.qa\/\",\"name\":\"Press Arabia\",\"description\":\"Arab News Headlines\",\"publisher\":{\"@id\":\"https:\/\/pressarabia.qa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pressarabia.qa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pressarabia.qa\/#organization\",\"name\":\"Press Arabia\",\"url\":\"https:\/\/pressarabia.qa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png\",\"contentUrl\":\"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png\",\"width\":200,\"height\":129,\"caption\":\"Press Arabia\"},\"image\":{\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/pressarabia.qa\/author\/admin01\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/","og_locale":"en_US","og_type":"article","og_title":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia","og_description":"NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta [\u2026]","og_url":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/","og_site_name":"Press Arabia","article_published_time":"2023-04-15T05:40:27+00:00","og_image":[{"url":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE="}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#article","isPartOf":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/"},"author":{"name":"admin","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2"},"headline":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT","datePublished":"2023-04-15T05:40:27+00:00","dateModified":"2023-04-15T05:40:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/"},"wordCount":559,"publisher":{"@id":"https:\/\/pressarabia.qa\/#organization"},"image":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage"},"thumbnailUrl":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/","url":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/","name":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT - Press Arabia","isPartOf":{"@id":"https:\/\/pressarabia.qa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage"},"image":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage"},"thumbnailUrl":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=","datePublished":"2023-04-15T05:40:27+00:00","dateModified":"2023-04-15T05:40:27+00:00","breadcrumb":{"@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#primaryimage","url":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE=","contentUrl":"https:\/\/ci5.googleusercontent.com\/proxy\/FSGZ-jg0wFTtQeIKMk4MqIiqO4rVQcGRPjhBQwRC8L32MfczH1WKthAZc7mGa6lkcAJUOuLGCJp3VOa9lvI1603XFN5YA_H3vl5jdUrQceLx0v7aC38t6Jcze3NDtBLF=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwODIwMSM1NTI3MjA4IzIwMjA0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/pressarabia.qa\/srpt-investor-news-rosen-top-ranked-global-counsel-encourages-sarepta-therapeutics-inc-investors-to-inquire-about-securities-class-action-investigation-srpt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pressarabia.qa\/"},{"@type":"ListItem","position":2,"name":"SRPT INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 SRPT"}]},{"@type":"WebSite","@id":"https:\/\/pressarabia.qa\/#website","url":"https:\/\/pressarabia.qa\/","name":"Press Arabia","description":"Arab News Headlines","publisher":{"@id":"https:\/\/pressarabia.qa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pressarabia.qa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pressarabia.qa\/#organization","name":"Press Arabia","url":"https:\/\/pressarabia.qa\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/","url":"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png","contentUrl":"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png","width":200,"height":129,"caption":"Press Arabia"},"image":{"@id":"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/pressarabia.qa\/author\/admin01\/"}]}},"_links":{"self":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts\/128895"}],"collection":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/comments?post=128895"}],"version-history":[{"count":0,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts\/128895\/revisions"}],"wp:attachment":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/media?parent=128895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/categories?post=128895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/tags?post=128895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}